"Weight reducing or anti-obesity drugs, currently available, ought to be used very judiciously," the Minister said while addressing the inaugural session of the 2-day "Asia Oceania Conference on ...

New study reveals that bacteria can survive antibiotic treatment through two fundamentally different "shutdown modes," not ...

NB-UVB phototherapy may restore adalimumab efficacy in chronic plaque psoriasis after treatment failure. Learn more about ...

The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...

New math model controls biological noise at single-cell level, offering a path to tackle cancer relapse and drug resistance.

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis ...

Since the pandemic in the early 2020s, people have been dealing with collective stressors. This has included social isolation ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

A new study reveals that bacteria can survive antibiotic treatment through two fundamentally different "shutdown modes," not ...